![Pei Jian Wang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Pei Jian Wang
Director of Finance/CFO at XinYu Pharmaceutical Co., Ltd.
Pei Jian Wang active positions
Companies | Position | Start | End |
---|---|---|---|
XinYu Pharmaceutical Co., Ltd.
![]() XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | Director of Finance/CFO | 2019-04-30 | - |
Investor Relations Contact | - | - | |
Corporate Secretary | 2019-04-30 | - |
Career history of Pei Jian Wang
Statistics
International
China | 2 |
Operational
Director of Finance/CFO | 1 |
Investor Relations Contact | 1 |
Corporate Secretary | 1 |
Sectoral
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
XinYu Pharmaceutical Co., Ltd.
![]() XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | Health Technology |
- Stock Market
- Insiders
- Pei Jian Wang
- Experience